Affiliation:
1. School of Medicine, University of Crete, 71003 Heraklion, Greece
2. First Department of Medical Oncology, Metropolitan Hospital of Neon Faliron, 18547 Athens, Greece
Abstract
The development of antimicrobial resistance (AMR), along with the relative reduction in the production of new antimicrobials, significantly limits the therapeutic options in infectious diseases. Thus, novel treatments, especially in the current era, where AMR is increasing, are urgently needed. There are several ongoing studies on non-classical therapies for infectious diseases, such as bacteriophages, antimicrobial peptides, and nanotechnology, among others. Nanomaterials involve materials on the nanoscale that could be used in the diagnosis, treatment, and prevention of infectious diseases. This review provides an overview of the applications of nanotechnology in the diagnosis and treatment of infectious diseases from a clinician’s perspective, with a focus on pathogens with AMR. Applications of nanomaterials in diagnosis, by taking advantage of their electrochemical, optic, magnetic, and fluorescent properties, are described. Moreover, the potential of metallic or organic nanoparticles (NPs) in the treatment of infections is also addressed. Finally, the potential use of NPs in the development of safe and efficient vaccines is also reviewed. Further studies are needed to prove the safety and efficacy of NPs that would facilitate their approval by regulatory authorities for clinical use.
Reference241 articles.
1. Michaud, C.M. (2009). Encyclopedia of Microbiology, Elsevier.
2. Trends in Infectious Disease Mortality in the United States during the 20th Century;Armstrong;JAMA,1999
3. The Australian Mortality Decline: Cause-Specific Mortality 1907–1990;Taylor;Aust. N. Z. J. Public Health,1998
4. GBD, and 2019 Child and Adolescent Communicable Disease Collaborators (2023). The Unfinished Agenda of Communicable Diseases among Children and Adolescents before the COVID-19 Pandemic, 1990–2019: A Systematic Analysis of the Global Burden of Disease Study 2019. Lancet Lond. Engl., 402, 313–335.
5. Antimicrobial Resistance Collaborators (2022). Global Burden of Bacterial Antimicrobial Resistance in 2019: A Systematic Analysis. Lancet Lond. Engl., 399, 629–655.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献